Targeted Therapy for Glioblastoma: Lessons Learned and Future Directions

Author(s): Nicole A Shonka , Suprit Gupta , Pankaj K. Singh .

Journal Name: Current Cancer Therapy Reviews

Volume 11 , Issue 1 , 2015

Become EABM
Become Reviewer

Graphical Abstract:


Glioblastoma is the most common adult malignant primary brain tumor, and carries a dismal prognosis. After initial standard radiation therapy and chemotherapy with temozolomide, few standard chemotherapy options are available. In the last two decades, a growing understanding of molecular pathogenesis of glioblastoma has turned our focus toward targeted therapy. This review will discuss our current understanding of gliomagenesis and highlight the clinical attempts to manipulate these vital pathways, describing past and current studies, and future directions.

Keywords: Cell signaling, glioblastoma, gliomagenesis, monoclonal antibodies, targeted therapy, tyrosine kinase inhibitors.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [44 - 58]
Pages: 15
DOI: 10.2174/157339471101150706122425

Article Metrics

PDF: 34